Monday, April 21, 2025
Home 2023

Yearly Archives: 2023

All News

Is Smart for Life (SMFL) $4.30, a Bargain Post Reverse Split?

Editor / Curator -
Psychedelic Stock Review

Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?

Editor / Curator -
Psychedelic Stock Review

The Ketamine Endgame. Silo Pharmaceutical (SILO).

Editor / Curator -
Psychedelic Stock Review

The Ketamine Cure (NY Times)

Editor / Curator -
All News

A Good Bear Market, is a Terrible Thing to Waste. How...

Editor / Curator -
2023 Watch List

The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel...

Editor / Curator -
2022 Watch List

Ardelyx (ARDX) Resubmits New Drug Application to FDA.

Editor / Curator -
Psychedelic Stock Review

Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.

Editor / Curator -
ARDX, Roland Rick Perry
2022 Watch List

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.

Editor / Curator -
2022 Watch List

Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.

Editor / Curator -
1...121314...18Page 13 of 18

Latest article

Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

All News Editor / Curator -
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.